SAMRATPH logo

Samrat Pharmachem Ltd

SAMRATPH·BSE·
233.00 -3.85 (-1.63%)
Market Cap70.46 Cr
PE Ratio10.13
Volume421
Day High - Low237.50 - 230.00
52W High-Low296.00 - 190.00
DocStoX Score
3.8/10
Poor
Fair Value
Sign in to see
ROE
-4.73%
Weak
P/E
10.13x
Cheap
Debt / Equity
0.16
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day230.00
237.50
52W190.00
296.00
DocStoX take

Supported by valuation (6.0), but held back by quality (2.1).

DocStoX score

Low confidence
3.8
/10
Poor
Quality
Weak
ROE -4.7%
Valuation
Fair
P/E 10.1×
Growth
Slow
Revenue +10.1% 5Y CAGR
Risk
Elevated
D/E 0.16
Momentum
Soft
41% of 52-week range

At a glance

Market Cap
₹70 Cr
52W High / Low
₹296 / ₹190
Dividend Yield
0.41%
Promoter Holding
49.09%
EPS (TTM)
₹23.01
Book Value
₹220.67

Key highlights

  • Low leverage — D/E 0.16
  • Undemanding at 10× earnings
  • Quality is weak (2.1/10)
  • Small ₹70 cr company — thinner liquidity
2 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Samrat Pharmachem Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.